Windham Capital Partners (formerly Windham Venture Partners) is a New York City-based venture capital firm focused on healthcare, with a particular emphasis on medical technology and digital health. Founded in 2006, the firm invests in companies developing life-saving and game-changing technologies across pharmaceutical, medical device, and digital health markets.
55% of their portfolio is in Healthcare. Average disclosed round size is $46.5M (across 34 rounds with reported amounts).
Portfolio
22
Fund Size
—
Top Stage
Series B
Last 12 Mo
0
Team
Alistair Erskine
Operating Partner
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
42 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 PainTEQ | Growth | — | Aug 2025 |
 Clever Care | Series A | $42M | Jan 2023 |
 Valera Health | Growth | $44.5M | Oct 2022 |
 Vergent Bioscience | Series B | $21.5M | Oct 2022 |
 Delfi Diagnostics, Inc. | Series B | — | Jul 2022 |
 Delfi | Series B | — | Jul 2022 |
| Delfi | Series B | $225M | Jan 2022 |
 Alto Neuroscience | Series A | $32M | Oct 2021 |
| Clever Care | Series B | $71M | Sep 2021 |
 Neuspera Medical | Series C | $65M | Jul 2021 |
| Valera Health | Seed | $3.8M | Feb 2021 |
| Delfi Diagnostics, Inc. | Series A | $100M | Jan 2021 |
| Delfi | Series A | $100M | Jan 2021 |
 SubjectWell | Series B | $35M | Jun 2019 |
| Neuspera Medical | Series B | $26M | Feb 2019 |
| NNuvaira, Inc. | Series C | $79M | Feb 2019 |
| NNuvaira, Inc. | Unknown | $79M | Jan 2019 |
 Nebula Genomics | Series A | — | Aug 2018 |
| PPersonal Genome Diagnostics (PGDx) | Series B | — | Jan 2018 |
 PGDx | Series B | — | Jan 2018 |
 Earlens | Series C | $73M | Jun 2017 |
| VVytronUS | Series C | $49M | Jul 2016 |
 Coravin | Series C | $13.6M | Jan 2016 |
 Welldoc | Series B | $22M | Dec 2015 |
| PPersonal Genome Diagnostics (PGDx) | Series A | $21.4M | Oct 2015 |
Page 1 of 2
Top Co-Investors
Northpond Ventures9 shared
Illumina Ventures9 shared
Menlo Ventures9 shared
AV8 Ventures9 shared
Samsara BioCapital9 shared
New Enterprise Associates8 shared
Cowen Healthcare Investments7 shared
Rock Springs Capital7 shared
T. Rowe Price6 shared
OrbiMed6 shared
Foresite Capital6 shared
Osage University Partners5 shared
Advanced Technology Ventures4 shared
Morgenthaler Ventures4 shared
Split Rock Partners4 shared
Versant Ventures4 shared
Open Field Capital4 shared
Eli Lilly and Company4 shared
Lightstone Ventures3 shared
Health Velocity Capital3 shared
Last updated: 20 October 2026